We believe this site might serve you best:

United States

United States

Language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

Our website does not fully support your browser.

We've detected that you are using an older version of Internet Explorer. Your commerce experience may be limited. Please update your browser to Internet Explorer 11 or above.

AACR (American Association for Cancer Research) 2019

Visit us at Booth #3412

  •  Georgia World Congress Center, Atlanta, GA.
  •  Friday, March 29, 2019 – Wednesday, April 3, 2019

Featured Products and Technologies

  • Functional bioassays to accelerate immunotherapy drug development
  • MSI analysis for immune-oncology
  • ccfDNA, miRNA and FFPE nucleic acid extraction
  • Real-time viability, cytotoxicity and apoptosis assays for 3D
  • Autophagy, inflammation and metabolism
  • Kinase biology
  • Targeted protein degradation
  • Protein:Protein interactions
  • NGS sample prep and QC

Learn More About Instrumentation Solutions

Spectrum Compact

Spectrum Compact: One compact CE system optimized for a broad range of applications

GloMax Discover

GloMax® Discover: State-of-the-art luminescence, fluorescence, UV-visible absorbance, BRET and FRET detection

Maxwell RSC 48

Maxwell® RSC 48: High precision nucleic acid purification with prefilled cartridges and preprogrammed methods

Scientific Poster Presentations for Cancer Biology, AACR 2019

Sunday, March 31, 2019 / 1:00pm – 5:00pm

Section 32

Poster 14

Real-time Apoptosis and Necrosis Detection in 3D Spheroid Cell Models
Andrew Niles

Monday, April 1, 2019 / 8:00am – 12:00pm

Section 9

Poster 9

New Bioluminescent Strategies to Measure Kinetics of Immune Cell-mediated Cytotoxicity
Maggie Bach

Section 10

Poster 12

Improved T Cell Activation Bioassays for Development of Bispecific Antibodies and Engineered T Cell Immunotherapies
Brad Swanson

Monday, April 1, 2019 / 1:00pm – 5:00pm

Section 35

Poster 7

A Comparison of Microsatellite Instability Analysis Methods for Detection of Mismatch Repair Deficiency
Samantha Lewis

Section 33

Poster 22

Measuring DNA Quantity, FFPE Degradation, and Genomic DNA Contamination of ccfDNA in a Single Assay
Trista Schagat

Section 25

Poster 17

Bridging MOA-based Reporter Bioassays with PBMC-based ADCC for Immunotherapy Drug Development
Mei Cong

Section 5

Poster 25

Novel Substrates for NanoLuc Luciferase with Improved Brightness and Signal Duration for Bioluminescence Imaging In Vivo
Joel Walker

Section 13

Poster 2

Monitoring AMP Concentration, The Universal Product of Diverse Enzymatic Reactions
Said Goueli

Tuesday, April 2, 2019 / 8:00am – 12:00pm

Section 13

Poster 15

Development of Novel Cell-based Bioassays for the Development of Biologics Targeting LAG-3 and PD-1xLAG-3
Jamison Grailer

Section 22

Poster 4

A Novel Bioluminescent Assay for the Selective Detection of Target Cell Killing in Mixed Cultures
Brock Binkowski

Tuesday, April 2, 2019 / 1:00pm – 5:00pm

Section 24

Poster 16

Quantitative Cell-based Bioassays to Advance Immunotherapy Programs Targeting Immune Checkpoint Receptors
Gopal Krishnan

Wednesday, April 3, 2019 / 8:00am – 12:00pm

Section 38

Poster 15

Sensitive Bioluminescent Assays for Monitoring Changes in Tumor and Immune Cell Metabolism
Donna Leippe

Section 14

Poster 19

Using Reporter-based Bioassays and Engineered TNFα and VEGF+ Target Cells to Measure Fc-mediated ADCC and CDC Activity of anti-TNFα and anti-VEGF Therapeutic Antibodies
Chris Heid

Share With a Friend

We will NOT sell your personal information, such as your name or email address, to third parties or use your email address to send you marketing materials. The email and names entered will only be used to identify the sender and recipient of the email.

Send Cancel